Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin., 68, 394, 10.3322/caac.21492 McGlynn, 2021, Epidemiology of hepatocellular carcinoma, Hepatology, 73, 4, 10.1002/hep.31288 Zheng, 2022, Cancer incidence and mortality in China, 2016, J Natl Cancer Cent, 2, 1, 10.1016/j.jncc.2022.02.002 Metrics, 2017, Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390, 1260, 10.1016/S0140-6736(17)32130-X WHO. Cancer screening 2012. Available from: http://www.who.int/cancer/prevention/diagnosis-screening/screening/en/. Heimbach, 2018, AASLD guidelines for the treatment of hepatocellular carcinoma, Hepatology, 67, 358, 10.1002/hep.29086 Omata, 2017, Asia–pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update, Hepatol Int, 11, 317, 10.1007/s12072-017-9799-9 Galle, 2018, EASL clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, 69, 182, 10.1016/j.jhep.2018.03.019 Zhang, 2004, Randomized controlled trial of screening for hepatocellular carcinoma, J Cancer Res Clin Oncol, 130, 417, 10.1007/s00432-004-0552-0 Harris, 2015, A value framework for cancer screening: advice for high-value care from the American college of physicians, Ann Intern Med, 162, 712, 10.7326/M14-2327 WHO. National cancer control programmes:policies and managerial guidelines - Second edition. 2002. Rognoni, 2016, Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses, Oncotarget, 7, 72343, 10.18632/oncotarget.11644 Facciorusso, 2019, Efficacy of regorafenib in hepatocellular carcinoma patients: a systematic review and meta-analysis, Cancers, 12, 10.3390/cancers12010036 Humphrey L., Deffebach M., Pappas M., et al. Screening for lung cancer: systematic review to update the U.S. preventive services task force recommendation 2013. Available from: https://www.uspreventiveservicestaskforce.org/. Lin J.S., Piper M.A., Perdue L.A., et al. Screening for colorectal cancer: a systematic review for the U.S. preventive services task force 2016. Available from: https://www.uspreventiveservicestaskforce.org/. Nelson H.D., Cantor A., Humphrey L., et al. Screening for breast cancer: a systematic review to update the 2009 U.S. preventive services task force recommendation 2016. Available from: https://www.uspreventiveservicestaskforce.org/. Aghoram, 2012, Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B, Cochrane Database Syst Rev Kansagara, 2014, Screening for hepatocellular carcinoma in chronic liver disease: a systematic review, Ann Intern Med, 161, 261, 10.7326/M14-0558 Singal, 2014, Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis, PLoS Med, 11, 10.1371/journal.pmed.1001624 Wun, 2003, Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B, Cochrane Database Syst Rev, 10.1002/14651858.CD002799 Singal, 2022, HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis, J Hepatol, 77, 128, 10.1016/j.jhep.2022.01.023 Kramer, 2009, Cancer screening: the clash of science and intuition, Annu Rev Med, 60, 125, 10.1146/annurev.med.60.101107.134802 Atiq, 2017, An assessment of benefits and harms of hepatocellular carcinoma surveillance in patients with cirrhosis, Hepatology, 65, 1196, 10.1002/hep.28895 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Wells G.A., Wells G., Shea B., et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014. NICE. Appendix 4 quality of case series form 2015. Available from: http://www.nice.org.uk/guidance/index Díaz-González, 2016, Surveillance for hepatocellular carcinoma, Best Pract Res Clin Gastroenterol, 30, 1001, 10.1016/j.bpg.2016.10.006 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Tanaka, 1990, Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma, Cancer, 66, 2210, 10.1002/1097-0142(19901115)66:10<2210::AID-CNCR2820661028>3.0.CO;2-7 Martínez Cerezo, 1993, Value of ultrasonography in the early diagnosis of hepatocellular carcinoma, Rev Esp Enferm Dig, 84, 311 Garcia Gullon, 1995, Usefulness of ultrasonography in the early diagnosis of hepatocarcinoma in patients with liver cirrhosis, Rev Esp Enferm Dig, 87, 798 Wong, 2000, Improved survival with screening for hepatocellular carcinoma, Liver Transpl, 6, 320, 10.1053/lv.2000.4875 Lu, 2001, Study of AFP andbimaging monitor diagnosis of small hepatocellular carcinoma in high-risk hepatocellular subjects, J Appl Radiol, 405 Chen, 2002, Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan, Int J Cancer, 98, 257, 10.1002/ijc.10122 Chen, 2003, Screening for liver cancer: results of a randomised controlled trial in Qidong, China, J Med Screen, 10, 204, 10.1258/096914103771773320 Youk, 2003, Early diagnosis and improved survival with screening for hepatocellular carcinoma, Taehan Kan Hakhoe Chi, 9, 116 Trevisani, 2004, Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival, Am J Gastroenterol, 99, 1470, 10.1111/j.1572-0241.2004.30137.x Kemp, 2005, Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease, J Gastroenterol Hepatol, 20, 873, 10.1111/j.1440-1746.2005.03844.x Taura, 2005, Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study, Oncol Rep, 14, 999 Van Vlierberghe, 2005, The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC?, Acta Gastroenterol Belg, 68, 403 Ando, 2006, Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease, J Clin Gastroenterol, 40, 942, 10.1097/01.mcg.0000225675.14594.d6 Cheung, 2006, Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong, Aliment Pharmacol Ther, 24, 573, 10.1111/j.1365-2036.2006.03029.x Tanaka, 2006, Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival, Liver Int, 26, 543, 10.1111/j.1478-3231.2006.01270.x Toyoda, 2006, Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan, Clin Gastroenterol Hepatol, 4, 1170, 10.1016/j.cgh.2006.06.007 Caumes, 2007, Epidemiology of hepatocellular carcinoma in Finistere. Prospective study from June 2002 to May 2003, Gastroenterol Clin Biol, 31, 259, 10.1016/S0399-8320(07)89370-5 Davila, 2007, Utilization of screening for hepatocellular carcinoma in the United States, J Clin Gastroenterol, 41, 777, 10.1097/MCG.0b013e3180381560 Gellert, 2007, Hepatocellular carcinoma in Sydney South West: late symptomatic presentation and poor outcome for most, Intern Med J, 37, 516, 10.1111/j.1445-5994.2007.01392.x Leykum, 2007, Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival, Clin Gastroenterol Hepatol, 5, 508, 10.1016/j.cgh.2007.01.014 Trevisani, 2007, Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?, Am J Gastroenterol, 102, 2448, 10.1111/j.1572-0241.2007.01395.x Pascual, 2008, Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice, Liver Int, 28, 682, 10.1111/j.1478-3231.2008.01710.x Silveira, 2008, Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis, Hepatology, 48, 1149, 10.1002/hep.22458 Stravitz, 2008, Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome, Am J Med, 121, 119, 10.1016/j.amjmed.2007.09.020 Wong, 2008, Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis, Liver Int, 28, 79, 10.1111/j.1478-3231.2007.01576.x El-Zayadi, 2010, Effect of surveillance for hepatocellular carcinoma on tumor staging and treatment decisions in Egyptian patients, Hepatol Int, 4, 500, 10.1007/s12072-010-9170-x Jou, 2010, Rates of surveillance and management of hepatocellular carcinoma in patients evaluated at a liver transplant center, Dig Dis Sci, 55, 3591, 10.1007/s10620-010-1366-3 Kuo, 2010, Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis, Eur J Cancer, 46, 744, 10.1016/j.ejca.2009.12.018 Noda, 2010, Regular surveillance by imaging for early detection and better prognosis of hepatocellular carcinoma in patients infected with hepatitis C virus, J Gastroenterol, 45, 105, 10.1007/s00535-009-0131-x Tong, 2010, Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic, Dig Dis Sci, 55, 826, 10.1007/s10620-009-1059-y Zapata, 2010, Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options?, Rev Esp Enferm Dig, 102, 484, 10.4321/S1130-01082010000800005 El-Serag, 2011, Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA, Gut, 60, 992, 10.1136/gut.2010.230508 Rodríguez, 2011, Gastroenterol Hepatol, 34, 524, 10.1016/j.gastrohep.2011.06.009 Stroffolini, 2011, Changing aetiological factors of hepatocellular carcinoma and their potential impact on the effectiveness of surveillance, Dig Liver Dis, 43, 875 Yang, 2011, Factors that affect risk for hepatocellular carcinoma and effects of surveillance, Clin Gastroenterol Hepatol, 9, 617, 10.1016/j.cgh.2011.03.027 Miquel, 2012, Factors related to survival in hepatocellular carcinoma in the geographic area of Sabadell (Catalonia, Spain), Rev Esp Enferm Dig, 104, 242, 10.4321/S1130-01082012000500004 Sarkar, 2012, Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans, J Viral Hepat, 19, 594, 10.1111/j.1365-2893.2011.01577.x Gaba, 2013, Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients, Ann Hepatol, 12, 766, 10.1016/S1665-2681(19)31318-3 Eltabbakh, 2015, Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting, Med Oncol, 32, 432, 10.1007/s12032-014-0432-7 Yeh, 2014, Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan, Hepatology, 59, 1840, 10.1002/hep.26703 Farrell, 2015, The evaluation of an automated recall programme for surveillance liver ultrasound in patients at increased risk of hepatocellular carcinoma, J Hepatol, 62, S443, 10.1016/S0168-8278(15)30568-7 Frey, 2015, Ultrasound surveillance for hepatocellular carcinoma: real-life performance in a hepatology outpatient clinic, Swiss Med Wkly, 145, w14200 Nusbaum, 2015, The effect of hepatocellular carcinoma surveillance in an urban population with liver cirrhosis, World J Gastroenterol, 21, 3035 Nusbaum, 2015, The effect of hepatocellular carcinoma surveillance in an urban population with liver cirrhosis, J Clin Gastroenterol, 49, e91, 10.1097/MCG.0000000000000306 Poh, 2015, Surveillance for hepatocellular carcinoma in a mixed-aetiology UK cohort with cirrhosis: does alpha-fetoprotein still have a role?, Eur J Gastroenterol Hepatol, 27, 638, 10.1097/MEG.0000000000000341 Thein, 2015, Improved survival in patients with viral hepatitis-induced hepatocellular carcinoma undergoing recommended abdominal ultrasound surveillance in ontario: a population-based retrospective cohort study, PLoS One, 10, 10.1371/journal.pone.0138907 Van Meer, 2015, Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands, J. Hepatol., 63, 1156, 10.1016/j.jhep.2015.06.012 Chin, 2016, The effect of omitting alfa-fetoprotein in surveillance of hepatocellular carcinoma, J Gastroenterol Hepatol, 31, 97 Costentin, 2016, Prospective evidence that hepatocellular carcinoma surveillance in patients with compensated viral cirrhosis increases the probability of curative treatment and survival taking into account lead-time bias (ANRS CO12 CIRVIR cohort), J Hepatol, 64, S194, 10.1016/S0168-8278(16)00141-0 Demma, 2016, False-negative liver ultrasound limits benefits of HCC surveillance, J Hepatol, 64, S340, 10.1016/S0168-8278(16)00483-9 Khalaf, 2016, Natural history of untreated HCC in a US cohort and the role of cancer surveillance, Gastroenterology, 150, S1130, 10.1016/S0016-5085(16)33816-1 Mittal, 2016, Impact of screening on survival in hepatocellular carcinoma patients with chronic hepatitis B-A regional U.S. population based study, Hepatology, 64, 669A Mittal, 2016, Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: a United States cohort, J Hepatol, 65, 1148, 10.1016/j.jhep.2016.07.025 Yerokun, 2016, HCC surveillance is associated with early tumor detection and improved survival: a multi-center United States study, Gastroenterology, 150, S1138, 10.1016/S0016-5085(16)33840-9 Chen, 2017, Early diagnosis and early treatment for liver cancer in Qidong: survival of patients and effectiveness of screening, Chin J Oncol, 946 Chaiteerakij, 2017, Surveillance for hepatocellular carcinoma reduces mortality: an inverse probability of treatment weighted analysis, Ann Hepatol, 16, 421, 10.5604/01.3001.0009.8597 Rich, 2017, Hepatocellular carcinoma surveillance using ultrasound and afp improves early detection and survival in patients with cirrhosis, Hepatology, 66, 730A Tong, 2017, Long-term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinoma, Hepatol Commun, 1, 595, 10.1002/hep4.1047 Dixon, 2018, Hepatocellular carcinoma (HCC) surveillance in clinical practice: a district general hospital single-centre experience, Gut, 67, A123 Ji, 2018, Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China, Sci Rep, 8, 12787, 10.1038/s41598-018-31119-9 Kim, 2018, Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area, Aliment Pharmacol Ther, 47, 1490, 10.1111/apt.14623 Toyoda, 2018, Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: a novel approach for the adjustment of lead-time bias, Liver Int, 38, 2260, 10.1111/liv.13927 Bui C.N. Impact of surveillance and early-stage versus late-stage hepatocellular carcinoma (HCC) detection on patient overall survival 2019. Chinnaratha, 2019, Improved survival of hepatocellular carcinoma patients diagnosed with a dedicated screening programme-a propensity score adjusted analysis, J Gastrointest Cancer, 50, 888, 10.1007/s12029-018-0171-7 Im, 2019, Surveillance rate and its impact on survival of hepatocellular carcinoma patients in South Korea: a cohort study, Cancer Res Treat, 51, 1357, 10.4143/crt.2018.430 Konerman, 2019, Frequency and outcomes of abnormal imaging in patients with cirrhosis enrolled in a hepatocellular carcinoma surveillance program, Liver Transpl, 25, 369, 10.1002/lt.25398 Piñero, 2019, Surveillance for hepatocellular carcinoma: does the place where ultrasound is performed impact its effectiveness?, Dig Dis Sci, 64, 718, 10.1007/s10620-018-5390-z Singal, 2021, Benefits and harms of hepatocellular carcinoma surveillance in a prospective cohort of patients with cirrhosis, Clin Gastroenterol Hepatol, 19, 1925, 10.1016/j.cgh.2020.09.014 Rich, 2017, Overdiagnosis: an understudied issue in hepatocellular carcinoma surveillance, Semin Liver Dis, 37, 296, 10.1055/s-0037-1608775 Forner, 2008, Diagnosis of hepatic nodules 20mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma, Hepatology, 47, 97, 10.1002/hep.21966 Rockey, 2009, American association for the study of liver diseases. Liver biopsy, Hepatology, 49, 1017, 10.1002/hep.22742